Exact Sciences (EXAS) Tops Q4 EPS by 17c
Tweet
Share
E-mail
Get Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Research and development: 7.63M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
Research and development: 7.63M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Exact Sciences (NASDAQ: EXAS) reported Q4 EPS of ($0.27), $0.17 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $647 million versus the consensus estimate of $637.34 million.
GUIDANCE:
Exact Sciences sees FY2024 revenue of $2.81-2.85 billion, versus the consensus of $2.83 billion.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c
- UBS Reiterates Neutral Rating on Pilgrim's Pride (PPC) on 'Challenging' Near-Term Fundamentals
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
